← Back to Search

LTBI ASSIST and CDC/NTCA guidelines for Latent Tuberculosis

N/A

Waitlist Available

Led By Maunank Shah, MD, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Student at Johns Hopkins School of Medicine, or Medical trainee at Hopkins Hospital or Bayview Program

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will assess if a web-based tool, LTBI-ASSIST, can help medical trainees understand and apply Latent Tuberculosis (TB) guidelines to improve clinical decision making.

Eligible Conditions

Latent Tuberculosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reported confidence with LTBI management [using a Likert scale questionnaire developed by study team]

Secondary outcome measures

Proportion of appropriate LTBI care selection

Time to LTBI care selection

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: LTBI ASSIST and CDC/NTCA guidelinesExperimental Treatment1 Intervention

The intervention group will have a link to both US guidelines, and the LTBI-ASSIST tool as resources to answer the case vignettes.

Group II: CDC/NTCA guidelines onlyActive Control1 Intervention

The control group will have a link to US guidelines only and use it as a resource to answer the case vignettes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

LTBI ASSIST and CDC/NTCA guidelines only

2023

N/A

~170

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,259 Previous Clinical Trials

14,820,485 Total Patients Enrolled

8 Trials studying Latent Tuberculosis

87,499 Patients Enrolled for Latent Tuberculosis

Maunank Shah, MD, PhDPrincipal InvestigatorHopkins University

2 Previous Clinical Trials

537 Total Patients Enrolled

1 Trials studying Latent Tuberculosis

399 Patients Enrolled for Latent Tuberculosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this research trial still an option for interested participants?

"Affirmative. According to clinicaltrials.gov, this study was first unveiled on June 1st and recently revised on the 2nd of that same month. It is currently recruiting 120 participants across single location."

Answered by AI

How many people are taking part in this exploration?

"Indeed, the information on clinicaltrials.gov attests to this experiment's active recruitment phase. The study was first published on June 1st 2023 and has been revised as recently as June 2nd. This trial is seeking 120 participants at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management

2023. "Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05772065.